Jazz Pharmaceuticals plc (JAZZ)
NASDAQ · Healthcare
Jazz Pharmaceuticals plc Revenue 2009–2025
Jazz Pharmaceuticals plc annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Jazz Pharmaceuticals plc revenue for the quarter ending March 31, 2026 was 1.1 B, a 19.06% increase year-over-year.
- Jazz Pharmaceuticals plc revenue for the twelve months ending March 31, 2026 was 4.1 B, a 4.70% increase year-over-year.
- Jazz Pharmaceuticals plc annual revenue for 2025 was 4.3 B, a 4.88% increase from 2024.
- Jazz Pharmaceuticals plc annual revenue for 2024 was 4.1 B, a 6.12% increase from 2023.
- Jazz Pharmaceuticals plc annual revenue for 2023 was 3.8 B, a 4.78% increase from 2022.
- Jazz Pharmaceuticals plc annual revenue for 2022 was 3.7 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Jazz Pharmaceuticals plc Earnings — FAQ
Jazz Pharmaceuticals plc (JAZZ) earnings over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see JAZZ's earnings history?
The chart and table above show Jazz Pharmaceuticals plc's earnings by year and by quarter, including the growth rate.